A FHIR has been lit on gICS: facilitating the standardised exchange of informed consent in a large network of university medicine.
Consent management
FHIR
Informed Consent
Medical data management
Patient rights
Journal
BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682
Informations de publication
Date de publication:
19 12 2022
19 12 2022
Historique:
received:
03
11
2021
accepted:
09
12
2022
entrez:
19
12
2022
pubmed:
20
12
2022
medline:
22
12
2022
Statut:
epublish
Résumé
The Federal Ministry of Education and Research of Germany (BMBF) funds a network of university medicines (NUM) to support COVID-19 and pandemic research at national level. The "COVID-19 Data Exchange Platform" (CODEX) as part of NUM establishes a harmonised infrastructure that supports research use of COVID-19 datasets. The broad consent (BC) of the Medical Informatics Initiative (MII) is agreed by all German federal states and forms the legal base for data processing. All 34 participating university hospitals (NUM sites) work upon a harmonised infrastructural as well as legal basis for their data protection-compliant collection and transfer of their research dataset to the central CODEX platform. Each NUM site ensures that the exchanged consent information conforms to the already-balloted HL7 FHIR consent profiles and the interoperability concept of the MII Task Force "Consent Implementation" (TFCI). The Independent Trusted Third-Party (TTP) of the University Medicine Greifswald supports data protection-compliant data processing and provides the consent management solutions gICS. Based on a stakeholder dialogue a required set of FHIR-functionalities was identified and technically specified supported by official FHIR experts. Next, a "TTP-FHIR Gateway" for the HL7 FHIR-compliant exchange of consent information using gICS was implemented. A last step included external integration tests and the development of a pre-configured consent template for the BC for the NUM sites. A FHIR-compliant gICS-release and a corresponding consent template for the BC were provided to all NUM sites in June 2021. All FHIR functionalities comply with the already-balloted FHIR consent profiles of the HL7 Working Group Consent Management. The consent template simplifies the technical BC rollout and the corresponding implementation of the TFCI interoperability concept at the NUM sites. This article shows that a HL7 FHIR-compliant and interoperable nationwide exchange of consent information could be built using of the consent management software gICS and the provided TTP-FHIR Gateway. The initial functional scope of the solution covers the requirements identified in the NUM-CODEX setting. The semantic correctness of these functionalities was validated by project-partners from the Ludwig-Maximilian University in Munich. The production rollout of the solution package to all NUM sites has started successfully.
Sections du résumé
BACKGROUND
The Federal Ministry of Education and Research of Germany (BMBF) funds a network of university medicines (NUM) to support COVID-19 and pandemic research at national level. The "COVID-19 Data Exchange Platform" (CODEX) as part of NUM establishes a harmonised infrastructure that supports research use of COVID-19 datasets. The broad consent (BC) of the Medical Informatics Initiative (MII) is agreed by all German federal states and forms the legal base for data processing. All 34 participating university hospitals (NUM sites) work upon a harmonised infrastructural as well as legal basis for their data protection-compliant collection and transfer of their research dataset to the central CODEX platform. Each NUM site ensures that the exchanged consent information conforms to the already-balloted HL7 FHIR consent profiles and the interoperability concept of the MII Task Force "Consent Implementation" (TFCI). The Independent Trusted Third-Party (TTP) of the University Medicine Greifswald supports data protection-compliant data processing and provides the consent management solutions gICS.
METHODS
Based on a stakeholder dialogue a required set of FHIR-functionalities was identified and technically specified supported by official FHIR experts. Next, a "TTP-FHIR Gateway" for the HL7 FHIR-compliant exchange of consent information using gICS was implemented. A last step included external integration tests and the development of a pre-configured consent template for the BC for the NUM sites.
RESULTS
A FHIR-compliant gICS-release and a corresponding consent template for the BC were provided to all NUM sites in June 2021. All FHIR functionalities comply with the already-balloted FHIR consent profiles of the HL7 Working Group Consent Management. The consent template simplifies the technical BC rollout and the corresponding implementation of the TFCI interoperability concept at the NUM sites.
CONCLUSIONS
This article shows that a HL7 FHIR-compliant and interoperable nationwide exchange of consent information could be built using of the consent management software gICS and the provided TTP-FHIR Gateway. The initial functional scope of the solution covers the requirements identified in the NUM-CODEX setting. The semantic correctness of these functionalities was validated by project-partners from the Ludwig-Maximilian University in Munich. The production rollout of the solution package to all NUM sites has started successfully.
Identifiants
pubmed: 36536405
doi: 10.1186/s12911-022-02081-4
pii: 10.1186/s12911-022-02081-4
pmc: PMC9762638
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
335Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 01KX2021
Organisme : Bundesministerium für Bildung und Forschung
ID : 01ZZ1803A
Organisme : Bundesministerium für Bildung und Forschung
ID : 01ZZ1801M
Informations de copyright
© 2022. The Author(s).
Références
J Transl Med. 2018 Sep 14;16(1):256
pubmed: 30217236
J Transl Med. 2015 Jun 04;13:176
pubmed: 26040848
BMC Med Inform Decis Mak. 2020 Dec 21;20(1):341
pubmed: 33349259
Eur J Epidemiol. 2014 May;29(5):371-82
pubmed: 24840228
Stud Health Technol Inform. 2022 May 25;294:674-678
pubmed: 35612174
Methods Inf Med. 2018 Jul;57(S 01):e66-e81
pubmed: 30016813
Methods Inf Med. 2018 Jul;57(S 01):e57-e65
pubmed: 30016812
Methods Inf Med. 2018 Jul;57(S 01):e92-e105
pubmed: 30016815
BMC Med Inform Decis Mak. 2020 Jun 5;20(1):103
pubmed: 32503529
Stud Health Technol Inform. 2021 May 24;278:126-133
pubmed: 34042885
J Biomed Inform. 2022 Jul;131:104096
pubmed: 35643273
Methods Inf Med. 2018 Jul;57(S 01):e82-e91
pubmed: 30016814